At-Home Drug of Abuse (DOA) Testing Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030
Page: 215 | Report Code: LS240311 | Research Suite: Report (PDF) & Market Data (Excel)
At-home drug of abuse (DOA) testing refers to the process of
conducting drug screening tests at a convenience of one's home or one's
personal environment these tests are designed to detect the presence of illicit
drugs or prescription medications in biological samples such as urine, saliva
or blood collected in collectible materials (cups or oral swabs) and test
strips or cartridges that indicate the presence of specific drugs through color
changes or digital readout. DOA testing offers individuals a quick and
confidential way to screen for drug use without the need for laboratory
analysis and testing kits are available for a wide range of substances.
MARKET
OVERVIEW
The global market valuation of At-Home Drug of Abuse (DOA)
Testing market was valued at approximately USD 3.5 billion in 2022 and is
projected to reach USD 7.2 billion by 2030 exhibiting a CAGR of 7%, these
testing kits provides privacy and convenience moreover with rapid results which
allows the individuals to take proactive tests towards substance abuse and
treatment plans accordingly is driving the growth of the market.
GROWTH
DRIVERS
The convenience factor has led to the increased adoption, especially among parents monitoring their children or individuals testing themselves directly at their own comfort level in a private space is one of a significant driver the market. The growing awareness and rising substance use of recreational drugs and risk associated with substance abuse has led to a greater demand for at home drug testing kits among individuals to detect and address to monitor drug use and promote accountability.
The growing trend of
telehealth and telemedicine services has increased access to recommendation of
at-home drug testing kits by the health professionals is contributing to the
growth of the market. The growing percentage on preventative health measures
and self-care has caused individuals to take proactive steps to monitor their
health and moreover the easy availability of the products on e-commerce or
online pharmacies has made DOA kits very easily accessible to a broader
consumer worldwide.
MARKET
SEGMENTATION:
·
By Type – test cup, test
strips and others
·
By Sample – saliva,
blood, urine and others
·
By Region - North America,
Europe, Asia Pacific, the Middle East and Africa, and South America.
At-Home
Drug of Abuse (DOA) Testing Market by Type Segment Review:
The test cups are also all in one drug testing kits because
it includes integrated testing panels that are used to screen various illicit
substances, specimen collection cups which eliminates the need for additional
sample containers and for collecting urine samples directly with a secure lid
to provide leakage and result indicators that are used for detection of drugs
simultaneously and these testing cups offers convenience and ease of use,
making it popular among individuals and families for conducting drug tests at
home and often preferred for their simplicity and accuracy in detecting
multiple drug classes simultaneously. The test strips are thin paper like
strips coated with chemical reagents that react with specific drugs or their
metabolites in urine simple and the color changing interprets the results,
basically the user dips the strip into the urine sample collected and observes
the change in color of the strip which demonstrates the result accordingly,
test trips are portable and provide quick results which makes it a convenient
option for at-home drug testing.
At-Home
Drug of Abuse (DOA) Testing Market by Sample Segment Review:
The saliva drug testing kits are noninvasive in nature and
are very easy to use, basically these kits involves
collection of saliva as a sample collected by using a swab or collection device
and further analyzing the saliva sample for the presence of drugs or their
metabolites. It is very quick in providing results and can detect recent drug
use which makes it suitable for the on-the-spot testing or monitoring drug use
in real time. Urine based drug testing is one of the most common methods used
for at home drug testing in which the user has to
collect a urine sample provided in a testing cup or container and then the user
has to use a test strip analyze the urine sample
for the drug presence in it, during, urine drug test is easy to administer by
the user and can detect a wide range of drugs and it is suitable for both
recent and past drug use, making it a versatile option for various testing
methods. Blood based drug testings are not commonly used as compared to saliva
based or urine-based drug testing due to invasive nature of collection of blood
sample usually the sample is collected from the fingertips and applied on the
testing device and further analyzed, blood test can detect drugs at lower
concentrations and it provides more precise results compared to saliva and
urine based tests.
At-Home
Drug of Abuse (DOA) Testing Market by Regional Analysis:
North America leads the global market due to the high
prevalence of drug use and presence of key global companies like Abbott
laboratories which offers a wide range of at home drug testing kits. Europe is
a significant market driven by increasing initiatives to combat drug abuse and
the European Union initiatives like “EU Drugs strategy 2021-2025". The
Pacific region represents significant growth opportunities fueled by increasing
awareness about drug abuse prevention and big influence of ecommerce and online
pharmacies. The Middle Africa is witnessing market growth due to improving
healthcare infrastructure and raising awareness about such abuse. South America
shows promising growth prospects driven by increasing drug abuse rates and
growing healthcare expenditure and the growth of ecommerce platforms.
Key
Challenges:
The accuracy and reliability of a home drug of at home drug
testing kits poses a significant challenge because the variability in testing
methodology and sample collection techniques may lead to false positives or
false negatives which leads to false treatment plans, collecting samples such
as urine or saliva accurately at home may be challenging for users which
further may compromise the integrity of the test results, like inadequate
sample collection may affect the detection of drug. Most of the at home drug
testing kits offer limited panels which is for only specific drugs or class of
drugs and that leads to the inability to test for a comprehensive range of
substances.
Competitive
Landscape:
The leading companies investing in research and development
to continuously innovate by adding more parameters for accuracy or including
more detection of drugs and improve the testing kits and develop user friendly
and more reliable testing solutions. The leading companies are providing
educational resources, awareness campaigns and training programs for consumers
and healthcare professionals to enhance product knowledge and how to properly
use their company testing kits which is also indirectly helping in marketing
and advertising of their company products. The leading companies are forming
strategic partnerships with pharmacies and retail chains and online pharmacies
to expand the market reach and product accessibility and offering the product
at competitive pricing and affordability for attracting price sensitive consumers
and capture market share to maintain the competitiveness in the market.
Global
Key Players:
·
Abbott
·
Drager AG
·
Hangzhou
·
Atlas
·
BioSciences
·
Siemens
·
Thermo Fisher
·
Roche
·
Bio-Rad
·
OraSure
Attributes |
Details |
Base Year |
2022 |
Trend Period |
2023 – 2030 |
Forecast Period |
2023 – 2030 |
Pages |
215 |
By Type |
Test
cup, test strips and others |
By Sample |
Blood, Urine, saliva and others |
By region |
North America, Europe, Asia Pacific,
the Middle East and Africa, and South America |
Company Profiles |
Abbott, Drager AG, Hangzhou, Atlas, BioSciences,
Siemens, Thermo Fisher, Roche, Bio-Rad, OraSure |
Edition |
1st edition |
Publication |
Feb 2024 |